Your browser doesn't support javascript.
loading
An electronic, unsupervised patient-reported Expanded Disability Status Scale for multiple sclerosis.
Romeo, Andrew R; Rowles, William M; Schleimer, Erica S; Barba, Patrick; Hsu, Wan-Yu; Gomez, Refujia; Santaniello, Adam; Zhao, Chao; Pearce, Jennifer R; Jones, J B; Cree, Bruce C; Hauser, Stephen L; Gelfand, Jeffrey M; Stewart, Walter F; Goodin, Douglas S; Bove, Riley M.
Afiliación
  • Romeo AR; UCSF MS Epic Study Group.
  • Rowles WM; UCSF MS Epic Study Group.
  • Schleimer ES; UCSF MS Epic Study Group.
  • Barba P; UCSF MS Epic Study Group.
  • Hsu WY; UCSF MS Epic Study Group.
  • Gomez R; UCSF MS Epic Study Group.
  • Santaniello A; UCSF MS Epic Study Group.
  • Zhao C; UCSF MS Epic Study Group.
  • Pearce JR; Plain Language Health, San Francisco, CA, USA.
  • Jones JB; Sutter Health, Palo Alto Medical Foundation Research Institute, Walnut Creek, CA, USA.
  • Cree BC; UCSF MS Epic Study Group.
  • Hauser SL; UCSF MS Epic Study Group.
  • Gelfand JM; UCSF MS Epic Study Group.
  • Stewart WF; Medcurio Inc., Oakland, CA, USA.
  • Goodin DS; UCSF MS and Neuroinflammation Center, Weill Institute for Neurosciences, Department of Neurology, Division of Neuroinflammation and Glial Biology, University of California San Francisco, San Francisco, CA, USA.
  • Bove RM; UCSF MS and Neuroinflammation Center, Weill Institute for Neurosciences, Department of Neurology, Division of Neuroinflammation and Glial Biology, University of California San Francisco, San Francisco, CA, USA.
Mult Scler ; 27(9): 1432-1441, 2021 08.
Article en En | MEDLINE | ID: mdl-33236967
ABSTRACT

BACKGROUND:

In persons with multiple sclerosis (MS), the Expanded Disability Status Scale (EDSS) is the criterion standard for assessing disability, but its in-person nature constrains patient participation in research and clinical assessments.

OBJECTIVE:

The aim of this study was to develop and validate a scalable, electronic, unsupervised patient-reported EDSS (ePR-EDSS) that would capture MS-related disability across the spectrum of severity.

METHODS:

We enrolled 136 adult MS patients, split into a preliminary testing Cohort 1 (n = 50), and a validation Cohort 2 (n = 86), which was evenly distributed across EDSS groups. Each patient completed an ePR-EDSS either immediately before or after a MS clinician's Neurostatus EDSS evaluation.

RESULTS:

In Cohort 2, mean age was 50.6 years (range = 26-80) and median EDSS was 3.5 (interquartile range (IQR) = [1.5, 5.5]). The ePR-EDSS and EDSS agreed within 1-point for 86% of examinations; kappa for agreement within 1-point was 0.85 (p < 0.001). The correlation coefficient between the two measures was 0.91 (<0.001).

DISCUSSION:

The ePR-EDSS was highly correlated with EDSS, with good agreement even at lower EDSS levels. For clinical care, the ePR-EDSS could enable the longitudinal monitoring of a patient's disability. For research, it provides a valid and rapid measure across the entire spectrum of disability and permits broader participation with fewer in-person assessments.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Diagnostic_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Esclerosis Múltiple Tipo de estudio: Diagnostic_studies Aspecto: Patient_preference Límite: Adult / Aged / Aged80 / Humans / Middle aged Idioma: En Revista: Mult Scler Asunto de la revista: NEUROLOGIA Año: 2021 Tipo del documento: Article
...